T80.61XD Other serum reaction due to administration of blood and blood products, subsequent encounter

Name of the Condition

• Other serum reaction due to administration of blood and blood products, subsequent encounter

Summary

This condition describes an adverse reaction to blood or blood products that occurs during a subsequent encounter, following an initial exposure. It involves immune or non-immune responses to components in the administered products, which may manifest as systemic or localized effects. The reaction is distinct from immediate transfusion reactions and requires documentation of prior exposure and ongoing clinical evaluation.

Causes

Reactions may arise from immune-mediated responses to foreign proteins in blood products, such as antibodies against donor antigens, or non-immune mechanisms like complement activation. Contamination, improper storage, or administration errors can also contribute. The specific cause often depends on the type of blood product (e.g., plasma, platelets) and patient sensitization history.

Risk Factors

• Prior exposure to blood or blood products
• History of allergic or transfusion reactions
• Underlying immune disorders (e.g., autoimmune conditions)
• Use of multiple blood product types
• Genetic predisposition to immune reactions

Symptoms

• Skin reactions (rash, itching, hives)
• Fever or chills
• Joint pain or swelling
• Headache or dizziness
• Nausea or vomiting
• Respiratory symptoms (e.g., wheezing, shortness of breath)
• Hypotension or tachycardia

Diagnosis

Diagnosis involves correlating clinical symptoms with a history of prior blood product administration. Laboratory tests (e.g., blood counts, coagulation studies) and imaging may help identify organ involvement. Documentation of the specific blood product, timing of reaction, and prior exposures is critical for confirmation.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying cause. This may include antihistamines for mild reactions, corticosteroids for inflammation, or epinephrine for severe cases. Supportive care, such as oxygen or fluid management, is provided as needed. Future transfusions may require pre-medication or specialized products.

Prognosis and Follow-Up

Prognosis varies based on reaction severity and promptness of treatment. Most mild reactions resolve with intervention, but severe cases may require extended monitoring. Follow-up ensures resolution of symptoms and assesses for delayed complications. Documentation of the reaction guides future transfusion practices.

Complications

• Anaphylaxis or severe allergic reactions
• Organ dysfunction (e.g., renal, hepatic)
• Transfusion-related acute lung injury (TRALI)
• Sepsis from contaminated products
• Delayed immune-mediated disorders

Lifestyle & Prevention

• Inform healthcare providers of prior transfusion reactions
• Use leukoreduced or washed blood products when indicated
• Follow pre-transfusion protocols (e.g., testing, consent)
• Monitor for symptoms during and after transfusions
• Maintain updated medical records of sensitization history

When to Seek Professional Help

Seek immediate care for symptoms like difficulty breathing, swelling, or severe pain. Contact a provider for persistent or worsening reactions, even if initially mild. Document all episodes for future medical and transfusion planning.

Tips for Medical Coders

Code T80.61XD is used for subsequent encounters of other serum reactions due to blood or blood products. Document the specific blood product, timing of reaction, and prior exposures. Ensure the encounter is classified as "subsequent" (not initial or acute) and that the reaction is attributed to the blood product, not other causes.